| CTRI Number |
CTRI/2022/07/044042 [Registered on: 15/07/2022] Trial Registered Prospectively |
| Last Modified On: |
14/07/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Yoga & Naturopathy |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
To see the effect of Jal Neti and Nadi Shodhan Pranayama in Glaucoma |
|
Scientific Title of Study
|
Effect of Jal Neti and Nadi Shodhan Pranayama (Anuloma-viloma Pranayama) on the clinical parameters of patients with primary open angle glaucoma (POAG) |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Jayvindra Singh |
| Designation |
Research Scholar |
| Affiliation |
University of Patanjali |
| Address |
University of Patanajli
Patanjali Yogpeeth
Hardwar UTTARANCHAL 249405 India |
| Phone |
9536011319 |
| Fax |
|
| Email |
jayrana319@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr VK Katiyar |
| Designation |
Professor |
| Affiliation |
University of Patanjali |
| Address |
University of Patanjali, Patanjali Yogpeeth,Bahadrabad
Hardwar UTTARANCHAL 249405 India |
| Phone |
9897000998 |
| Fax |
|
| Email |
vktmafma20@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr VK Katiyar |
| Designation |
Professor |
| Affiliation |
University of Patanjali |
| Address |
University of Patanjali, Patanjali Yogpeeth,Bahadrabad
Hardwar UTTARANCHAL 249405 India |
| Phone |
9897000998 |
| Fax |
|
| Email |
vktmafma20@gmail.com |
|
|
Source of Monetary or Material Support
|
| University of Patanjali, Haridwar |
|
|
Primary Sponsor
|
| Name |
University of Ptatanjali |
| Address |
University of Patanjali, Patanjali Yogpeeth, Haridwar, Uttarakhand |
| Type of Sponsor |
Other [University] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Jayvindra Singh |
University of Patanjali |
Department of Yoga Science, University of Patanjali, Patanjali Yogpeeth, Haridwar Hardwar UTTARANCHAL |
9536011319
jayrana319@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethical Committee, University of Patanjali |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: H401||Open-angle glaucoma, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Anuloma viloma pranayama, jala neti |
Anuloma viloma pranayama and jala neti are yoga practices. |
| Comparator Agent |
Control |
No intervention will be given to the participants who are not assigned to active intervention. |
|
|
Inclusion Criteria
|
| Age From |
40.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
(i) Persons with ages between 40 and 65 years
(ii) Patients diagnosed with primary open angle glaucoma and currently on eye drop medication
(iii) Persons willing to take part in the study |
|
| ExclusionCriteria |
| Details |
(i) Patients with history of intraocular surgery/laser in previous 3 months, malignancy, ocular trauma, angle closure glaucoma.
(ii) Patients having any systemic disease (diabetes mellitus, hypertension, hyperthyroid etc).
(iii) Patients taking part in any other research study involving yoga or other mind body interventions. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
(i) Intra ocular pressure
(ii) Visual fields
(iii) Optical coherence tomography
(iv) Visual acuity test |
Baseline
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
(i) Intra ocular test
(ii)Visual field
(iii) Optical coherence tomography
(iv) Visual acuity test |
3 months |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "24"
Final Enrollment numbers achieved (India)="30" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
18/07/2022 |
| Date of Study Completion (India) |
30/12/2023 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Completed |
| Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
Effect of yoga on intra-ocular pressure in patients with glaucoma: A systematic review and meta-analysis |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response - Proposals should be directed to [jayrana319@gmail.com].
- For how long will this data be available start date provided 01-08-2023 and end date provided 01-08-2026?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
Modification(s)
|
Globally the prevalence of glaucoma is 3.54 percent for the population aged 40 to 80 years and is expected to increase from 76 million to 111.8 million individuals between 2020 and 2040. The pharmacological treatment of glaucoma mainly involves reducing the elevated IOP levels with drugs such as alpha-agonists, prostaglandins and β-blockers, although the envisaged results of the current medical regimen are not satisfying and sufficient. In recent years, an increased interest of using complementary and alternative therapies is seen for the treatment of glaucoma. Yoga is one of the most popular and widely used non-pharmacological interventions mainly comprising of practices involving breathing manipulation (pranayama), physical postures (asana) and mental awareness or meditation (dhyana). The evident effects of yoga on stress reduction, improvement of quality of life and general wellbeing could make it a relatively safe and economical add on treatment for categories of patients including those with primary open angle glaucoma. Nadishodhan pranayama and jal neti kriya are two yoga practices which are used by Yoga and Ayurveda therapists for various ailments including primary open angle glaucoma. However, there have been very few studies which examine the effects of yoga practices on primary open angle glaucoma. Also these studies have methodological limitations, therefore present randomized controlled trial is planned to investigate the effects of nadishodhan pranayama and jal neti on patients primary open angle glaucoma. |